CME and CFTC Clash Over On-Chain Perpetual Futures

The US derivatives market is witnessing an unusual standoff between the CME Group, the largest derivatives exchange operator, and its regulator, the Commodity Futures Trading Commission (CFTC), over the introduction of blockchain-based perpetual futures products. The CFTC recently approved the listing of crypto perpetual futures, also known as perps, by the prediction markets platform Kalshi and cryptocurrency exchange Coinbase, sparking a lawsuit from the CME Group. The CME claims that the CFTC is mislabeling these products and misapplying the law, as futures contracts typically have an expiration date, whereas perps allow traders to take a position on an asset's price without any deadline. The lawsuit argues that these perps are detrimental to the CME's long-dated futures products and that the CFTC's sudden approval did not consider the potential consequences. The tension between the two entities escalated around the start of the Iran conflict, which saw a surge in interest in perpetual contracts on oil prices traded on offshore decentralized finance (DeFi) exchanges. Proponents of the CFTC's reform agenda are expressing frustration and outrage over the CME's stance, with some viewing it as an attempt by a large incumbent to stifle innovation and competition. The CME's chairman, Terry Duffy, has been vocal about his opposition to perps, citing concerns over the definition of swaps and the need for clear regulations. The CFTC, on the other hand, has taken a more permissive approach, allowing registered entities, including the CME, to offer these products. The regulator's chairman, Mike Selig, has defended the agency's decision, stating that the CME's lawsuit is 'wholly inappropriate.' The dispute has significant implications for the US approach to the rapidly growing perps market, with non-US perps volume reportedly reaching $60 trillion in volume last year. As the case awaits federal court action, the CME is preparing its arguments, which include claims that the CFTC rubber-stamped the Kalshi application without proper review. The outcome of this battle will have far-reaching consequences for the US derivatives market and the regulation of perps.